Skip to main content

Table 1 Expression of IGF2BP2 according to clinicopathological features of 60 pancreatic cancer patients

From: Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway

CharacteristicHighLowP-value
Age31290.586
 ≥ 65 years1617 
 < 65 years1512 
Sex32280.63
 Male2120 
 Female118 
Grade  0.034*
 Good23 
 Moderate1910 
 Poor233 
TNM  0.02*
 I&II2212 
 III&IV917 
Size  < 0.001*
 ≥ 2.5 cm208 
 < 2.5 cm923 
CA199  0.342
 ≥ 1003310 
 < 100116 
  1. *Statistical significant difference